Rare mutations in the DLGAP2 gene have been identified with autism. In separate studies, de novo duplications were found in patients with ASD (Marshall et al., 2008; Pinto et al., 2010).
Molecular Function
The encoded protein is a membrane-associated guanylate kinase localized at the post-synaptic density in neuronal cells.
External Links
References
Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Structural variation of chromosomes in autism spectrum disorder.
Dlgap2 homozygous KO mice show no change in locomotion, no change in screen touches (exploratory behaviors), no change in reward reinforced choice behavior, increase in visual discrimination learning, increased cognitive flexibility in reversal learning paradigm, decreased cognition as measured by increased reaction times in visual discrimination and reversal learning.
References
Type
Title
Author, Year
Primary
Learning and reaction times in mouse touchscreen tests are differentially impacted by mutations in genes encoding postsynaptic interacting proteins SYNGAP1, NLGN3, DLGAP1, DLGAP2 and SHANK2
Model Type:
Genetic LOF
Model Genotype:
Homozygous
Mutation:
Mutant mice with dlgap2 exons 9-10 replaced with a selection cassette in targeted mice that created a frameshift between exons 8 and 11. the targeting vector replaced 1.8kb of dlgap2 genomic dna (x14822401 to x14824243; ensemble build 69) with ires-lacz-neo cassette.
Allele Type: Knockout
Strain of Origin: C57BL/6*129S5
Genetic Background: C57BL/6*129S5
ES Cell Line: E14TG2a
Mutant ES Cell Line: E14TG2a
Model Source: University of Edinburgh
Model Type:
Genetic LOF
Model Genotype:
Heterozygous
Mutation:
Mutant mice with dlgap2 exons 9-10 replaced with a selection cassette in targeted mice that created a frameshift between exons 8 and 11. the targeting vector replaced 1.8kb of dlgap2 genomic dna (x14822401 to x14824243; ensemble build 69) with ires-lacz-neo cassette.
Allele Type: Knockout
Strain of Origin: C57BL/6*129S5
Genetic Background: C57BL/6*129S5
ES Cell Line: E14TG2a
Mutant ES Cell Line: E14TG2a
Model Source: University of Edinburgh
Description: Decrease in the number of trials from first presentation to 80% correct criterion; decrease in the number of correction trials to reach criterion
Description: No change in the number of trials from first presentation to 80% correct criterion; decrease in the number of correction trials to reach criterion